Two melanoma treatments approved for PBS listing
24 December 2019
In a boost for melanoma patients across Australia, the Federal Government’s PBAC has recommended subsidised access to immunotherapy treatment for high risk early-stage and advanced-stage melanoma patients. Two melanoma treatments are recommended by the PBAC for PBS listing - nivolumab for resected Stage III/IV (high risk) metastatic melanoma, and the combination ipilimumab and nivolumab as first-line therapy for Stage IV (advanced) melanoma.
Co-Medical Directors of Melanoma Institute Australia, Professor Georgina Long and Professor Richard Scolyer, said providing subsidised access to these treatments was wonderful news for melanoma patients and their families around Australia, as until now, they could only access these treatments through clinical trials or on compassionate grounds, or face costs of tens of thousands of dollars.
‘Our clinical trials have proven nivolumab is effective in preventing melanoma recurrence and its spread to other organs including the brain, lungs and liver in the majority of high risk resected Stage III patients,’ said Professor Georgina Long. ‘Our trials have also proven the effectiveness of the combination immunotherapy as front line treatment for Stage IV melanoma patients where their disease has already spread to other organs, including the brain.’
‘Providing certainty of access to these treatments via the PBS will be life-changing and life-saving, and we applaud the Federal Government for this decision,’ added Professor Richard Scolyer.
Shown in photo: Melanoma Institute Australia's Co-Medical Directors - Professor Georgina Long and Professor Richard Scolyer
In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.
Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
“I had a complete response within about six months. All of my tumours disappeared."
‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'
MIA's Co-Medical Director, Professor Richard Scolyer, has achieved a Google Scholar h-index of 100.
We know what Melanoma March means to our community, so when we had to cancel our physical events, we created Melanoma March Virtual so that everyone across Australia could still connect to honour loved ones and support each other.
A must-read personal account by Garry Maddox in The Sydney Morning Herald of how immunotherapy is revolutionising melanoma treatment.
On Friday, a publication that lays out the steps needed to find out if a systematic screening program for melanoma would benefit all Australians was published in the Australia & New Zealand Journal of Public Health.
Melanoma March events have been cancelled. A Virtual March will be held on Sunday 29th March. Read this statement from MIA CEO Matthew Browne.
Thank you to the thousands of Aussies who bought ‘Game On Mole‘ t-shirts, took selfies, shared t-shirt pics on social media and started lifesaving conversations around sun safety and skin health.
Melanoma patients now have greater access to subsidised immunotherapy thanks to additional treatments today being listed on the PBS.
Brisbane couple Leon and Tamra Betts were, like thousands of others around Australia, on the couch watching MAFS when newlywed Natasha ran through her weekly beauty routine. When they heard the 26-year-old mention solarium use, they were shocked, and then saddened, prompting this open letter to all young Australians.
Professor Richard Scolyer, Co-Medical Director of Melanoma Institute Australia, will welcome international attendees this weekend to a sold-out, two-day course on ‘Pigmented Lesions and Other Hot Topics in Dermatopathology’.
It is time for a reality check on solariums.
They have no place in anyone’s beauty routine.
Throughout January our community created, hosted and participated in some amazing events, each of them helping us on our quest to reach zero deaths from melanoma.
Australian television presenter, interior designer and mother Kyly Clarke has been announced as the new Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign Melanoma March.
Melanoma Institute Australia has recently partnered with three other organisations to boost support for melanoma patients and their carers across Australia.
Melanoma patients and their families across Western Australia will benefit from strengthened and expanded services with the merging of melanomaWA and Melanoma Institute Australia.
Australian researchers have played a critical role in the discovery of a potential new test to predict which early stage melanoma patients are at high risk of their disease recurring and progressing.